Westell Technologies to Participate in The Benchmark Micro Cap Discovery Conference
Get Alerts WSTL Hot Sheet
Join SI Premium – FREE
AURORA, Ill.--(BUSINESS WIRE)-- Westell Technologies, Inc. (NASDAQ: WSTL), a leading provider of in-building wireless, intelligent site management, cell site optimization, and outside plant solutions, today announces that CEO, Tom Gruenwald, and CFO, Tom Minichiello, will participate in The Benchmark Company Micro Cap Discovery One-on-One Conference in Chicago on Thursday, December 10, 2015 from 8:00 a.m. to 2:30 p.m. CT. The conference is being held at the Palmer House Hilton Hotel, 17 East Monroe Street, Chicago, IL.
About Westell Technologies
Westell Technologies, Inc. is a leading provider of in-building wireless, intelligent site management, cell site optimization, and outside plant solutions focused on innovation and differentiation at the edge of communication networks, where end users connect. The Company's comprehensive set of products and solutions enable service providers and network operators to improve performance and reduce operating expenses. With millions of products successfully deployed worldwide, Westell is a trusted partner for transforming communication networks into high quality, reliable systems. For more information, please visit www.westell.com.
Twitter – Investor Relations: @Westell_IRTwitter – Company: @Westell_TechStockTwits: Westell_IR
View source version on businesswire.com: http://www.businesswire.com/news/home/20151202005156/en/
Westell Technologies, Inc.
Tom Minichiello
Chief Financial
Officer
+1 (630) 375 4740
[email protected]
Source: Westell Technologies, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SONATA Launches as a New Doctor-Led Preventive Healthcare Membership Bridging the Gap Between Deep Testing and Personalized Care
- FEWEST AMERICANS LIVING PAYCHECK TO PAYCHECK IN FIVE YEARS, BUT DEBT.COM SURVEY REVEALS A HIDDEN FINANCIAL ANXIETY
- Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share